A global offering for population genomics and life science powered by AWS
G42 Healthcare, the Abu Dhabi-based leading health tech company and a subsidiary of artificial intelligence and cloud computing company G42, has announced a partnership with Amazon Web Services (AWS) to develop new global genomics, proteomics, and biobanking service.
G42 Healthcare owns the region’s largest Omics Centre of Omics Excellence in Abu Dhabi, which can deliver over 500,000 whole-genome sequences per year.
“Our offering aims to leverage the extensive omics data management and bioinformatics solutions hosted globally on AWS at our customers’ fingertips. For us and AWS, this collaboration is about much more than data; it is about value,” stated Ashish Koshy, CEO, G42 Healthcare.
“The cooperation between G42 Healthcare and AWS is an exciting milestone to provide on-demand service for multi-omics data globally,” remarked Jens Dommel, Head of Public Sector Healthcare, EMEA, Amazon Web Services.